Clinical trials: Contraceptive Devices
Chlamydia, Gonorrhea
Randomized Trial of Home Versus Clinic-based Screening for Sexually Transmitted Infections
This study randomizes women using long-acting reversible methods of contraception to home-based STD screening through the mail compared to screening available in a clinical setting.
- Trial name
- NCT01184157
- Testing
- Home screening, Clinic screening
- Where
- United States
- Sponsor
- Washington University School of Medicine
Breast Feeding, Contraception
Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Objectives To clarify the relationship between postpartum (2 weeks) use of progestin-only vs. combined oral contraceptive pills and the outcomes of breastfeeding continuation, infant growth, contraceptive method continuation, and…
- Trial name
- NCT01465022
- Testing
- Combined estrogen-progestin pill, Progestin-only pill
- Volunteers
- 197 people, healthy volunteers welcome
- Sponsor
- University of New Mexico
Unintended Pregnancy, Contraception
Contraceptive Choice Center
The Contraceptive Choice Center will use an innovative-model of contraceptive care which was developed as a part of the Contraceptive CHOICE Project (CHOICE).
- Conditions
- Unintended Pregnancy, Contraception, Family Planning
- Trial name
- C3 (NCT02633631)
- Where
- United States
- Volunteers
- 2,664 people, healthy volunteers welcome
- Sponsor
- Washington University School of Medicine
Urinary Tract Infections
Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years
The objective of this study is to determine the magnitude and clinical relevance of a potential drug-drug interaction of GSK3882347 with midazolam (MDZ) in healthy participants.
- Trial name
- NCT05760261
- Testing
- Midazolam, GSK3882347
- Where
- United Kingdom
- Volunteers
- 27 people, healthy volunteers welcome
- Sponsor
- GlaxoSmithKline
Temporomandibular Disorders
Effects of Mandibular Exercises Effect on Pain Perception and Sensitivity in Mandibular Myofascial Pain
The effectiveness of mandibular exercises as a treatment of muscular Orofacial Pain is yet unknown. This study hypothesized that training exercises can be an effective therapy improving pain perception.
- Trial name
- NCT03339739
- Testing
- Isometric mandibular exercises, Isotonic mandibular exercises, Counseling group
- Volunteers
- 45 people
- Sponsor
- Universidad Nacional Andres Bello
Healthy Males, Male Contraceptive
Oral T7 Oral Testosterone in Man
The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.
- Trial name
- Oral T7 (NCT00842751)
- Testing
- First Intervention (7 days), First Washout (7 days), Second Intervention (7 days)
- Where
- United States
- Volunteers
- 11 people, healthy volunteers welcome
- Sponsor
- University of Washington
Contraception, Postpartum Period
Evaluation of an mHealth SMS Dialogue Strategy to Meet Women's and Couples' Postpartum Contraceptive Needs in Kenya
Meeting women's need for postpartum family planning is has been acknowledged as a global priority in maternal and child health. The prevention of unintended pregnancies in sub-Saharan African countries, which carry the highest…
- Trial name
- Mobile WACh XY (NCT02781714)
- Testing
- Two-way SMS
- Where
- 2 sites in Kenya
- Volunteers
- 260 people
- Sponsor
- University of Washington
Contraceptive Usage
Multilevel Family Planning Intervention
This study seeks to develop and evaluate a multi-level intervention to satisfy couples' unmet need for family planning in rural Uganda.
- Trial name
- NCT04262882
- Testing
- Multilevel Family Planning Intervention, Time and attention matched control
- Where
- 2 sites in Uganda
- Volunteers
- 160 people, healthy volunteers welcome
- Sponsor
- The University of Texas at San Antonio
IUD
Trans Caesarean Intra Uterine Contraceptive Device Insertion Versus Conventional Postpartum 6 Weeks Insertion
To compare immediate post-placental intrauterine contraceptive device insertion versus conventional placement at 6 weeks interval (often referred to as delayed or interval insertion) as regard to:- 1. Patient satisfaction. 2.
- Trial name
- IUDinsertion (NCT06023849)
- Testing
- IUD insertion
- Where
- Egypt
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Al-Azhar University
Contraceptive Device; Complications, Quality of Life
Quality of Life After Laparoscopic Removal of Essure®
A lot of patients seem to complain after hysteroscopic tubal occlusion by Essure® device with a worce quality of life. Investigators' hypothesis is that Essure® laparoscopic removal may improve quality of life.
- Trial name
- ABLIMCO (NCT03281564)
- Testing
- Quality of life after Essure® removal
- Where
- France
- Volunteers
- 474 people
- Sponsor
- Hospices Civils de Lyon
Contraception
A Multi-center, Open-label, Randomized, Parallel Group Study to Evaluate Pharmacokinetic Profile, Effects on the Mechanisms of Contraceptive Efficacy and Safety of Two Progestin-only Patches Containing Different Doses of Levonorgestrel (LNG)
WHAT IS THE STUDY PRODUCT? The study product is a contraceptive patch, which has the study drug on the patch. The patch is applied directly to the skin and it contains Levonorgestrel (LNG) in a time-release form.
- Trial name
- CCN009 (NCT01166412)
- Testing
- levonorgestrel patch with BMI 32 kg/m2 to <40 kg/m2, levonorgestrel patch with BMI <32 kg/m2
- Where
- 6 sites in United States
- Volunteers
- 121 people, healthy volunteers welcome
- Sponsor
- Premier Research
Female Contraception
Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive
Participants in the study will use mifepristone 50 mg once-a-week for one year as a contraceptive. With this, we want to confirm that the chances of getting pregnant while using this contraceptive are very small.
- Trial name
- WOMEN&More (NCT06394999)
- Testing
- Mifepristone 50 mg
- Where
- 14 sites in Netherlands
- Volunteers
- 615 people, healthy volunteers welcome
- Sponsor
- Leiden University Medical Center
Contraceptive Usage, Bleeding Due to Intrauterine Contraceptive Device
Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector
The main side-effect of Implanon is the changes induces in bleeding patterns including amenorrhea, infrequent to irregular bleeding and frequent and prolonged bleeding; without any previous symptom and it was characterized as…
- Trial name
- NCT01392157
- Testing
- copper-releasing intrauterine device, ENG-releasing implant, LNG-releasing intrauterine system
- Where
- Brazil
- Volunteers
- 300 people, healthy volunteers welcome
- Sponsor
- University of Campinas, Brazil
Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus
"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition
The goal of this clinical trial is to learn if Estetrol/Drospirenone inhibit ovulation in quick-starting method. It will also learn about the safety of Estetrol/Drospirenone. The main questions it aims to answer are: 1.
- Conditions
- Ultrasound Finding: Ovulation Inhibition, Ovarian Activities, Cervical Mucus, Serum Hormonal Profile
- Trial name
- NCT06396221
- Testing
- Estetrol 15 mg/Drospirenone 3 mg (24/4), Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7)
- Where
- Thailand
- Volunteers
- 36 people, healthy volunteers welcome
- Sponsor
- Chulalongkorn University
Contraception, Contraceptive Usage
Contraception Navigator Program
The goal of this study is to pilot test the IN-Control Birth Control Navigator Program in Central Indiana for use by adolescents who would like to access birth control.
- Conditions
- Contraception, Contraceptive Usage, Health Care Utilization
- Trial name
- NCT05691270
- Testing
- IN-Control (Birth Control Navigator Program)
- Where
- United States
- Volunteers
- 18 people
- Sponsor
- Indiana University
Contraception
Contraceptive Effectiveness of Sino-implant (II) in China
A cohort study to Evaluate the contraceptive effectiveness of Sino-implant (II) during the 3rd and 4th years of use in Chinese women
- Trial name
- NCT01936454
- Where
- 5 sites in China
- Volunteers
- 538 people, healthy volunteers welcome
- Sponsor
- FHI 360
Migraine, Migraine;Menstrual
Oral Contraceptive Pill Compared With Vitamin E in Women With Migraine
Open-label randomized controlled trial to study the efficacy of continuous daily use of ethinylestradiol/levonorgestrel (30/150 µg/day) compared with vitamin E (400 IU/day) in the treatment of women with menstrually-related and…
- Trial name
- WHATT (NCT04007874)
- Testing
- Ethinylestradiol/levonorgestrel, Vitamin E
- Where
- Netherlands
- Volunteers
- 360 people
- Sponsor
- Leiden University Medical Center
IUD, Contraceptive Implant
Quick Start of Highly Effective Contraception
This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).
- Conditions
- IUD, Contraceptive Implant, Contraception, Birth Control
- Trial name
- NCT02076217
- Testing
- Copper T-380 IUD, LNG IUD, Contraceptive implant Nexplanon
- Where
- United States
- Volunteers
- 270 people
- Sponsor
- University of Utah
Contraceptive Use, Unintended Pregnancy
MyNewOptions: An Online Study of Reproductive Life Planning and Contraceptive Action Planning
The purpose of this web-based study is to determine whether reproductive life planning (RLP), with or without contraceptive action planning (RLP+), will result in reduced risk of unintended pregnancy when compared to an…
- Trial name
- MyNewOptions (NCT02100124)
- Testing
- Reproductive Life Planning (RLP), Contraceptive Action Planning, Contraception information
- Where
- United States
- Volunteers
- 987 people
- Sponsor
- Milton S. Hershey Medical Center
Breast Cancer
Analysis of Data From the Women's Contraceptive and Reproductive Experiences (CARE) Study
This study will continue to analyze data collected by the Women's Contraceptive and Reproductive Experiences (CARE) study. The CARE study was designed to evaluate the association between reproductive factors and risk of breast…
- Trial name
- NCT00341159
- Where
- United States
- Volunteers
- 9,257 people
- Sponsor
- National Human Genome Research Institute (NHGRI)